Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Tabula Rasa HealthCare is a health information services business based in the US. Tabula Rasa HealthCare shares (TRHC) are listed on the NASDAQ and all prices are listed in US Dollars. Tabula Rasa HealthCare employs 1,602 staff and has a trailing 12-month revenue of around $357.1 million.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $6.07 |
|---|---|
| 52-week range | $2.09 - $10.92 |
| 50-day moving average | $4.54 |
| 200-day moving average | $4.11 |
| Wall St. target price | $6.60 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.73 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $6.07 from 2023-01-31
| 1 week (2023-01-25) | 1.17% |
|---|---|
| 1 month (2022-12-29) | N/A |
| 3 months (2022-10-29) | N/A |
| 6 months (2022-07-29) | 36.40% |
| 1 year (2022-02-02) | -36.77% |
|---|---|
| 2 years (2021-02-02) | -88.31% |
| 3 years (2020-01-31) | 58.07 |
| 5 years (2018-02-01) | 35.71 |
Valuing Tabula Rasa HealthCare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Tabula Rasa HealthCare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Tabula Rasa HealthCare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.2944. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Tabula Rasa HealthCare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
| Revenue TTM | $357.1 million |
|---|---|
| Gross profit TTM | $97.9 million |
| Return on assets TTM | -11.43% |
| Return on equity TTM | -555.2% |
| Profit margin | -38.99% |
| Book value | $-1.27 |
| Market capitalisation | $173.5 million |
TTM: trailing 12 months
We're not expecting Tabula Rasa HealthCare to pay a dividend over the next 12 months.
Over the last 12 months, Tabula Rasa HealthCare's shares have ranged in value from as little as $2.09 up to $10.915. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tabula Rasa HealthCare's is 1.5194. This would suggest that Tabula Rasa HealthCare's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.